Associations between Complete Remissions (CRs) with 7+3 Induction Chemotherapy for Acute Myeloid Leukemia and 2-3 Year Survival ("Potential Cure") over the Past Four Decades: Analysis of SWOG Trial Data
Publication
, Conference
Othus, M; Garcia-Manero, G; Godwin, J; Weick, JK; Anderson, JE; Stirewalt, D; Appelbaum, FR; Erba, HP; Estey, EH
Published in: BLOOD
December 7, 2017
Duke Scholars
Published In
BLOOD
EISSN
1528-0020
ISSN
0006-4971
Publication Date
December 7, 2017
Volume
130
Location
Atlanta, GA
Publisher
AMER SOC HEMATOLOGY
Conference Name
59th Annual Meeting of the American-Society-of-Hematology (ASH)
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Othus, M., Garcia-Manero, G., Godwin, J., Weick, J. K., Anderson, J. E., Stirewalt, D., … Estey, E. H. (2017). Associations between Complete Remissions (CRs) with 7+3 Induction Chemotherapy for Acute Myeloid Leukemia and 2-3 Year Survival ("Potential Cure") over the Past Four Decades: Analysis of SWOG Trial Data. In BLOOD (Vol. 130). Atlanta, GA: AMER SOC HEMATOLOGY.
Othus, Megan, Guillermo Garcia-Manero, John Godwin, James K. Weick, Jeanne E. Anderson, Derek Stirewalt, Frederick R. Appelbaum, Harry P. Erba, and Elihu H. Estey. “Associations between Complete Remissions (CRs) with 7+3 Induction Chemotherapy for Acute Myeloid Leukemia and 2-3 Year Survival ("Potential Cure") over the Past Four Decades: Analysis of SWOG Trial Data.” In BLOOD, Vol. 130. AMER SOC HEMATOLOGY, 2017.
Othus M, Garcia-Manero G, Godwin J, Weick JK, Anderson JE, Stirewalt D, et al. Associations between Complete Remissions (CRs) with 7+3 Induction Chemotherapy for Acute Myeloid Leukemia and 2-3 Year Survival ("Potential Cure") over the Past Four Decades: Analysis of SWOG Trial Data. In: BLOOD. AMER SOC HEMATOLOGY; 2017.
Othus, Megan, et al. “Associations between Complete Remissions (CRs) with 7+3 Induction Chemotherapy for Acute Myeloid Leukemia and 2-3 Year Survival ("Potential Cure") over the Past Four Decades: Analysis of SWOG Trial Data.” BLOOD, vol. 130, AMER SOC HEMATOLOGY, 2017.
Othus M, Garcia-Manero G, Godwin J, Weick JK, Anderson JE, Stirewalt D, Appelbaum FR, Erba HP, Estey EH. Associations between Complete Remissions (CRs) with 7+3 Induction Chemotherapy for Acute Myeloid Leukemia and 2-3 Year Survival ("Potential Cure") over the Past Four Decades: Analysis of SWOG Trial Data. BLOOD. AMER SOC HEMATOLOGY; 2017.
Published In
BLOOD
EISSN
1528-0020
ISSN
0006-4971
Publication Date
December 7, 2017
Volume
130
Location
Atlanta, GA
Publisher
AMER SOC HEMATOLOGY
Conference Name
59th Annual Meeting of the American-Society-of-Hematology (ASH)
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology